Opus Genetics
IRD
43 hedge funds and large institutions have $4.38M invested in Opus Genetics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 8 closing their positions.
850% more call options, than puts
Call options by funds: $19K | Put options by funds: $2K
100% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 6
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
32% more capital invested
Capital invested by funds: $3.32M → $4.38M (+$1.06M)
13% more funds holding
Funds holding: 38 → 43 (+5)
1.99% more ownership
Funds ownership: 9.66% → 11.65% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Voss Capital
Houston,
Texas
|
+$219K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$102K |
| 3 |
Renaissance Technologies
New York
|
+$86K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$47.9K |
| 5 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
+$32.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RB
Richmond Brothers
Jackson,
Michigan
|
-$204K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$115K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$65.2K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$56.5K |
| 5 |
Morgan Stanley
New York
|
-$31.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$25 | +22 | +440% |
|
IRD Hedge Fund Activity: Q4 2024 in Review
43 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q4 2024, worth a combined $4.38M — up 32% from $3.32M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new IRD positions and 8 closed out — a net gain of 6 holders — while 12 added to existing stakes and 6 trimmed.
The largest buyer was Voss Capital, opening a new position worth an estimated $219K. The largest seller was Richmond Brothers, exiting entirely with an estimated $204K sold.
- 43 institutional investors held Opus Genetics (IRD) as of Q4 2024, up from 38 in Q3 2024.
- Funds reported $4.38M of Opus Genetics stock for Q4 2024, up 32% quarter-over-quarter.
- 14 funds opened new Opus Genetics positions in Q4 2024 and 8 closed out, a net change of +6 holders.
- The largest Opus Genetics buyer in Q4 2024 was Voss Capital, an estimated $219K added.
- The largest Opus Genetics seller in Q4 2024 was Richmond Brothers, an estimated $204K sold.
Based on aggregated 13F filings for Q4 2024.